Citius Pharmaceuticals, Inc.CTXRNASDAQ

Revenue (LTM)

Net Income (LTM)

$-37M

+4.4% YoY

Free Cash Flow

$-27M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	0	0	0	0	0
Gross Profit	-0	-0↓9.0%	-0↓8.1%	-0↓7.9%	-0↓2.2%
Operating Income	-24	-33↓41.6%	-37↓10.3%	-42↓14.3%	-39↑8.3%
Net Income	-23	-34↓45.5%	-33↑3.3%	-39↓20.3%	-37↑4.4%
EBITDA	-23	-33↓43.7%	-32↑3.4%	-39↓21.6%	-38↑1.1%
EPS Diluted	-5.64	-5.76↓2.1%	-5.57↑3.3%	-5.97↓7.2%	-3.38↑43.4%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	70	42↓40.5%	26↓36.5%	3↓87.7%	4↑30.8%
Total Current Assets	73	45↓38.8%	34↓22.9%	14↓58.6%	28↑96.4%
Total Assets	142	114↓20.0%	104↓9.1%	117↑12.6%	131↑12.2%
Total Current Liabilities	4	5↑13.8%	6↑27.6%	36↑519.7%	45↑25.4%
Total Liabilities	10	11↑9.6%	12↑15.2%	43↑249.4%	53↑25.5%
Total Equity	132	103↓22.2%	91↓11.7%	70↓22.8%	68↓3.6%
Total Debt	1	1↓20.7%	0↓29.0%	0↓45.4%	2↑589.8%
Net Debt	-69	-41↑40.7%	-26↑36.6%	-3↑88.5%	-2↑18.4%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	-24	-28↓17.0%	-29↓2.5%	-28↑3.0%	-27↑5.8%
Capital Expenditure	-40	0	0	0	0
Free Cash Flow	-64	-28↑55.9%	-29↓2.5%	-28↑3.0%	-27↑5.8%
Stock-Based Comp	1	4↑168.5%	7↑69.4%	12↑78.9%	11↓8.5%
Net Change in Cash	56	-28↓150.5%	-15↑46.3%	-23↓52.5%	1↑104.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance